ViCentra announced the appointment of former Dexcom and Medtronic Diabetes leaders to new executive roles.
The company appointed Karen Baxter, former VP and GM at Dexcom, as SVP of sales for Europe, and Jay Little, a longtime commercialization and market access executive at Medtronic Diabetes, as VP of strategy and business development.
Baxter and Little bring nearly 40 years of combined experience in commercializing diabetes-related medical devices.
They join the company following its $85 million funding round announced last month, as ViCentra continues to advance its Kaleido patch pump system.
No comment
Author summary: ViCentra expands leadership team with industry veterans.